This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Toxic effect of other and unspecified substances
ST19_TOXIC_EFFECT_OTHER_UNSPE_SUBST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
493 |
4. Check minimum number of eventsNone |
493 |
5. Include endpointsNone |
493 |
6. Filter based on genotype QC (FinnGen only) |
493 |
Control definitions (FinnGen only)
- Control exclude
- ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T5[1-9]|T6[0-5]
- Name in latin
- Effectus toxicus substantiarum aliarum sive non specificatarum
Similar endpoints
↥List of similar endpoints to
Toxic effect of other and unspecified substances
based on the number of shared cases.
Similar with more cases:
- Toxic effects of substances chiefly nonmedicinal as to source
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 493 | 261 | 232 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.10 |
| Median age at first event (years) | 33.54 | 30.09 | 37.42 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 444
- Matched controls
- 4439
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
+∞
323.0
351
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
76.7
227.0
254
76
T36
ICD-10 Finland
Poisoning by systemic antibiotics
47.4
186.2
231
99
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
18.7
103.1
169
141
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
55.0
94.9
112
27
N05AH04
ATC
quetiapine; oral
8.7
86.4
234
504
N05AH03
ATC
olanzapine; systemic
13.8
80.1
149
157
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
11.9
76.4
154
190
N05BA01
ATC
diazepam; systemic, rectal
9.7
73.5
169
264
N05AA02
ATC
levomepromazine; systemic
20.7
73.1
112
71
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
32.9
69.6
92
35
T65.8
ICD-10 Finland
Toxic effect: Toxic effect of other specified substances
+∞
66.3
62
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
7.3
62.6
177
368
N05BA04
ATC
oxazepam; oral
5.9
60.2
221
640
N06AB04
ATC
citalopram; systemic
6.2
58.2
192
483
N05CD07
ATC
temazepam; oral
11.2
58.0
117
137
N07BB01
ATC
disulfiram; oral
12.3
57.1
109
114
N05AX08
ATC
risperidone; systemic
9.7
54.3
119
161
N03AG01
ATC
valproic acid; systemic, rectal
10.5
54.1
113
140
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
30.6
52.2
70
27
F10.20
ICD-10 Finland
Alcohol dependence currently independent
28.4
51.2
70
29
F29
ICD-10 Finland
Unspecified nonorganic psychosis
11.3
50.4
100
111
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
19.1
50.1
78
49
P15
ICPC
Chronic alcohol abuse
19.6
50.0
77
47
N06AB03
ATC
fluoxetine; oral
6.9
49.0
139
276
N06AX11
ATC
mirtazapine; oral
4.7
48.5
230
829
N05CF01
ATC
zopiclone; oral
4.9
48.1
209
687
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
44.2
47.3
58
15
XF400
NOMESCO Finland
ECG with 12 standard connections
7.0
46.7
129
245
N06AX16
ATC
venlafaxine; oral
5.9
46.7
154
369
B18.2
ICD-10 Finland
Chronic viral hepatitis C
29.2
46.5
63
25
F60.9
ICD-10 Finland
Personality disorder, unspecified
32.8
45.8
60
21
N03AE01
ATC
clonazepam; systemic
12.3
45.7
86
85
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
8.1
45.5
111
175
F10.09
ICD-10 Finland
Alcohol intoxication UNS
22.6
45.2
66
34
F10.25
ICD-10 Finland
Alcohol dependence continuous use
30.7
44.3
59
22
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
78.3
44.0
49
7
F10.24
ICD-10 Finland
Alcohol depence active use
35.4
43.5
56
18
N05AF03
ATC
chlorprothixene; systemic
16.7
43.0
70
49
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
19.3
40.3
62
37
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.6
39.9
133
315
P19
ICPC
Drug abuse
27.8
39.5
54
22
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
24.9
39.0
55
25
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
41.2
38.7
48
13
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
29.2
38.6
52
20
Z72.2
ICD-10 Finland
Drug use
40.2
37.7
47
13
C07AA05
ATC
propranolol; systemic
4.5
37.0
161
502
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
5.1
36.7
133
342
N06AB06
ATC
sertraline; oral
5.5
36.7
122
285
N05AX12
ATC
aripiprazole; systemic
8.7
35.7
81
111
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.8
35.0
109
234
N05BA12
ATC
alprazolam; oral
6.2
34.8
102
203
N03AX09
ATC
lamotrigine; oral
7.7
33.9
83
128
N05BA02
ATC
chlordiazepoxide; systemic
23.3
33.4
48
23
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
40.9
33.1
41
11
F20.9
ICD-10 Finland
Schizophrenia, unspecified
13.7
33.1
58
48
P18
ICPC
Medication abuse
59.1
32.8
38
7
T51.0
ICD-10 Finland
Toxic effect: Ethanol
+∞
32.7
31
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
51.8
32.1
38
8
N05AB03
ATC
perphenazine; systemic, rectal
10.0
32.0
66
76
AA1AD
NOMESCO Finland
CT of head and brain
4.4
31.5
131
382
X57
ICD-10 Finland
Unspecified privation
16.9
31.2
50
33
N05BA06
ATC
lorazepam; systemic, sublingual
10.2
30.9
63
71
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
63.1
30.6
35
6
WX892
NOMESCO Finland
Monitored bed care
8.0
30.3
72
105
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
25.6
30.2
42
18
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
6.1
30.2
89
176
N05BE01
ATC
buspirone; oral
12.4
30.0
55
50
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
40.2
29.8
37
10
F61.0
ICD-10 Finland
Mixed personality disorders
14.3
29.7
51
40
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
11.0
29.7
58
60
N05AD01
ATC
haloperidol; systemic
12.9
29.0
52
45
WX730
NOMESCO Finland
Conventional respirator
25.7
28.9
40
17
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.1
28.8
74
121
TKC20
NOMESCO Finland
Catheterisation of bladder
8.3
28.8
66
91
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
26.6
28.4
39
16
N05AH02
ATC
clozapine; systemic
11.1
28.4
55
56
P29
ICPC
Psychological sympt/compl other
5.5
28.0
90
197
P16
ICPC
Acute alcohol abuse
17.3
27.8
44
28
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
9.7
27.8
58
68
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
40.7
27.5
34
9
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
66.4
27.3
31
5
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
8.0
27.3
64
91
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
49.0
26.9
32
7
Z3231
NOMESCO Finland
Registered nurse
3.4
26.7
165
658
N05AN01
ATC
lithium; oral
11.6
26.6
50
48
Z2446
NOMESCO Finland
Social worker
6.0
26.5
78
153
X59
ICD-10 Finland
Exposure to unspecified factor
3.6
26.4
143
515
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.8
26.3
80
163
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.9
26.3
126
410
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
47.4
25.9
31
7
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
47.4
25.9
31
7
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
22.9
25.2
36
17
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
17.7
25.0
39
24
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
95.7
24.9
27
*
N06AB05
ATC
paroxetine; oral
6.0
24.9
73
142
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
15.6
24.4
40
28
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
28.6
23.9
32
12
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
132.1
23.8
25
*
ZY000
NOMESCO Finland
Hospital inpatient
16.5
23.8
38
25
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
6.1
23.1
66
124
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
10.1
22.9
46
50
N06AX03
ATC
mianserin; oral
7.6
22.6
54
79
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
84.5
21.9
24
*
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
230.9
21.8
22
*
F31.8
ICD-10 Finland
Other bipolar affective disorders
11.2
21.6
41
40
F99
ICD-10 Finland
Mental disorder, not otherwise specified
12.1
21.4
39
35
N06AA12
ATC
doxepin; systemic
7.8
21.3
50
71
P72
ICPC
Schizophrenia
11.8
21.1
39
36
N03AX16
ATC
pregabalin; oral
3.2
21.0
130
506
Z72.1
ICD-10 Finland
Alcohol use
16.9
20.9
33
21
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
80.8
20.9
23
*
N06AX12
ATC
bupropion; oral
4.9
20.8
73
173
S18
ICPC
Laceration/cut
2.8
20.8
189
941
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
50.6
20.4
24
5
A06AD11
ATC
lactulose; oral
4.5
20.3
77
198
EBA00
NOMESCO Finland
Extraction of tooth
2.6
20.1
205
1088
T65.2
ICD-10 Finland
Toxic effect: Tobacco and nicotine
+∞
19.9
19
*
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
+∞
19.9
19
*
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
9.9
19.8
40
44
N02AX02
ATC
tramadol; systemic, rectal
2.7
19.8
193
997
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
110.0
19.7
21
*
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
110.0
19.7
21
*
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
208.9
19.7
20
*
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
42.2
19.7
24
6
P99
ICPC
Psychological disorders other
7.0
19.5
49
77
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
48.3
19.4
23
5
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
48.3
19.4
23
5
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.8
19.4
153
692
S01.0
ICD-10 Finland
Open wound of scalp
5.2
19.3
63
138
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
12.6
19.1
34
29
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.7
19.1
92
293
N05AA01
ATC
chlorpromazine; systemic, rectal
19.8
18.9
28
15
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
25.0
18.9
26
11
N05AD03
ATC
melperone; systemic
22.0
18.8
27
13
Z72.8
ICD-10 Finland
Other problems related to lifestyle
46.1
18.4
22
5
R41.0
ICD-10 Finland
Disorientation, unspecified
13.8
18.2
31
24
F60.2
ICD-10 Finland
Dissocial personality disorder
34.5
18.1
23
7
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
21.2
18.0
26
13
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
21.2
18.0
26
13
N06AA09
ATC
amitriptyline; systemic
5.0
17.9
60
135
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
69.6
17.9
20
*
N03AF01
ATC
carbamazepine; oral, rectal
7.6
17.8
42
60
P01
ICPC
Feeling anxious/nervous/tense
3.2
17.8
107
403
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
38.5
17.8
22
6
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.4
17.7
262
1659
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
99.1
17.7
19
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
99.1
17.7
19
*
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
6.4
17.7
47
80
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
17.6
180
938
L17
ICPC
Foot/toe symptom/complaint
2.8
17.6
132
575
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
25.3
17.5
24
10
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.5
17.4
91
308
N05AC02
ATC
thioridazine; oral
14.0
17.2
29
22
Z71.8
ICD-10 Finland
Other specified counselling
2.7
17.1
150
714
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
9.0
17.1
36
43
SPAT1265
SPAT
Breathalyser
14.9
17.0
28
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
17.0
60
143
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
+∞
16.8
16
*
F39
ICD-10 Finland
Unspecified mood [affective] disorder
8.3
16.7
37
48
A46
ICD-10 Finland
Erysipelas
3.7
16.7
78
241
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
176.4
16.6
17
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
16.6
194
1078
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.3
16.5
65
172
S06.0
ICD-10 Finland
Concussion
3.6
16.5
80
255
N04AA02
ATC
biperiden; systemic
10.7
16.2
31
31
F61
ICD-10 Finland
Mixed and other personality disorders
49.5
16.1
19
*
N05CF02
ATC
zolpidem; oral
3.0
16.1
108
435
Z3226
NOMESCO Finland
Physiotherapist
3.1
16.1
100
381
V03AA01
ATC
NA
15.3
16.0
26
18
T74.1
ICD-10 Finland
Physical abuse
8.1
16.0
36
48
P76
ICPC
Depressive disorder
4.2
16.0
63
167
R07.4
ICD-10 Finland
Chest pain, unspecified
2.8
15.9
119
513
ZY010
NOMESCO Finland
Hospital outpatient
4.3
15.7
60
154
N06AB10
ATC
escitalopram; oral
2.6
15.7
136
636
Z91.5
ICD-10 Finland
Personal history of self-harm
+∞
15.7
15
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
23.1
15.7
22
10
R02
ICPC
Shortness of breath/dyspnoea
3.7
15.6
72
220
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
39.6
15.5
19
5
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
9.7
15.4
31
34
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
15.4
107
438
F51.0
ICD-10 Finland
Nonorganic insomnia
3.0
15.2
96
370
S22.3
ICD-10 Finland
Fracture of rib
6.0
15.1
42
76
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.2
14.9
58
152
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
58.8
14.9
17
*
N05AF05
ATC
zuclopenthixol; systemic
13.9
14.9
25
19
M79.6
ICD-10 Finland
Pain in limb
2.4
14.8
169
914
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.8
14.7
50
114
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.2
14.7
46
96
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
9.9
14.7
29
31
T52.9
ICD-10 Finland
Toxic effect: Organic solvent, unspecified
+∞
14.7
14
*
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
82.9
14.7
16
*
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
154.9
14.5
15
*
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
20.0
14.4
21
11
Z2221
NOMESCO Finland
Medical doctor
2.4
14.4
145
734
N03AX12
ATC
gabapentin; oral
3.1
14.3
87
324
WX110
NOMESCO Finland
Local anesthesy
2.4
14.3
339
2565
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
5.3
14.2
44
91
ZXD05
NOMESCO Finland
Urgent procedure
2.3
14.2
162
873
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.2
14.1
55
144
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
14.1
158
841
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.5
14.0
129
621
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.8
14.0
40
75
K08.3
ICD-10 Finland
Retained dental root
5.3
14.0
43
88
L03
ICPC
Low back symptom/complaint
2.5
14.0
129
622
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
18.3
14.0
21
12
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
55.2
13.9
16
*
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
24.7
13.9
19
8
R05
ICPC
Cough
2.6
13.9
117
535
F05.9
ICD-10 Finland
Delirium, unspecified
14.2
13.9
23
17
J01MA12
ATC
levofloxacin; systemic
3.1
13.7
84
314
SAA01
NOMESCO Finland
Simple examination of mouth
2.4
13.7
352
2729
K92.0
ICD-10 Finland
Haematemesis
11.4
13.7
25
23
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
6.3
13.6
36
61
N05AF01
ATC
flupentixol; systemic
16.9
13.6
21
13
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
7.3
13.4
32
47
A28
ICPC
Limited function/disability NOS
3.9
13.4
57
162
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.9
13.3
37
67
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
13.3
74
260
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
41.4
13.2
16
*
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
9.2
13.2
27
31
K02.1
ICD-10 Finland
Caries of dentine
2.2
13.1
305
2231
188
Kela drug reimbursment
Psychosis requiring demanding treatment
13.5
13.1
22
17
F34.1
ICD-10 Finland
Dysthymia
5.3
13.0
40
82
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.3
12.9
49
125
EBA15
NOMESCO Finland
Extraction of large number of teeth
7.2
12.9
31
46
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.2
12.8
49
126
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.0
12.8
53
147
T42.4
ICD-10 Finland
Poisoning: Benzodiazepines
72.0
12.7
14
*
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
72.0
12.7
14
*
N06AB08
ATC
fluvoxamine; oral
8.0
12.6
28
37
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
+∞
12.6
12
*
R11
ICD-10 Finland
Nausea and vomiting
3.6
12.5
59
183
N06AA06
ATC
trimipramine; systemic
8.1
12.3
27
35
A02BC02
ATC
pantoprazole; systemic
2.1
12.2
261
1815
N06AX05
ATC
trazodone; oral
7.6
12.2
28
39
X58
ICD-10 Finland
Exposure to other specified factors
2.7
12.2
93
401
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
18.7
12.1
18
10
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.1
12.1
48
128
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.5
12.0
31
51
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.5
11.9
35
68
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.7
11.9
54
162
N07BA03
ATC
varenicline; oral
4.1
11.9
47
125
S10
ICPC
Boil/carbuncle
5.3
11.9
36
73
SPAT1240
SPAT
Therapeutic discussion
2.7
11.8
88
373
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.8
11.8
51
147
Y07
ICD-10 Finland
Other maltreatment
13.0
11.7
20
16
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.5
11.7
109
520
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
31.0
11.7
15
5
SPAT1307
SPAT
Psychosocial counselling and guidance
3.2
11.7
64
220
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
19.6
11.7
17
9
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
66.8
11.7
13
*
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
66.8
11.7
13
*
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
66.8
11.7
13
*
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
66.8
11.7
13
*
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
23.6
11.6
16
7
A04
ICPC
Weakness/tiredness general
2.9
11.6
75
291
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
11.6
117
582
WX290
NOMESCO Finland
Other blockade of nerve
2.0
11.5
254
1772
F19.50
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic
123.1
11.5
12
*
SPAT1227
SPAT
Substance abuse rehabilitation
15.6
11.4
18
12
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
11.3
51
152
V01.9
ICD-10 Finland
Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident
36.0
11.3
14
*
SPAT1234
SPAT
Support of social functional capacity
5.1
11.3
35
73
Z03
ICPC
Housing/neighbourhood problem
25.8
11.2
15
6
X78
ICD-10 Finland
Intentional self-harm by sharp object
20.7
11.2
16
8
XF600
NOMESCO Finland
Bloodpressure measurement
4.3
11.2
41
102
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
11.1
87
380
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
44.5
11.0
13
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
6.8
11.0
27
42
R53
ICD-10 Finland
Malaise and fatigue
2.4
11.0
103
495
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
12.3
10.9
19
16
F60.8
ICD-10 Finland
Other specific personality disorders
16.0
10.9
17
11
N05CD02
ATC
nitrazepam; oral
16.0
10.9
17
11
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
5.2
10.9
33
67
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
7.0
10.8
26
39
P06
ICPC
Sleep disturbance
3.0
10.8
65
239
A03
ICPC
Fever
2.4
10.8
108
534
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
22.1
10.7
15
7
F13.21
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment
61.5
10.7
12
*
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
10.4
10.6
20
20
P28
ICPC
Limited function/disability (P)
14.7
10.6
17
12
N05AB01
ATC
dixyrazine; systemic
14.7
10.6
17
12
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.8
10.5
45
129
F11.9
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder
112.6
10.5
11
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
10.4
41
109
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
10.4
264
1909
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
9.9
10.4
20
21
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.7
10.3
29
54
U04
ICPC
Incontinence urine
5.9
10.3
28
50
ZXD35
NOMESCO Finland
Usual procedure
6.2
10.3
27
46
F41.1
ICD-10 Finland
Generalized anxiety disorder
4.0
10.2
41
111
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.3
10.2
51
166
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
11.7
10.1
18
16
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
10.1
151
891
R06.0
ICD-10 Finland
Dyspnoea
2.4
10.1
97
468
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
41.1
10.0
12
*
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
17.2
9.9
15
9
N01
ICPC
Headache
2.6
9.9
77
332
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
11.0
9.9
18
17
N05BB01
ATC
hydroxyzine; systemic
3.8
9.9
42
120
R74
ICPC
Upper respiratory infection acute
2.0
9.8
171
1067
N17
ICPC
Vertigo/dizziness
3.1
9.8
55
193
N06AA04
ATC
clomipramine; systemic
7.7
9.8
22
30
-1
NOMESCO Finland
NA
1.9
9.8
186
1199
P74
ICPC
Anxiety disorder/anxiety state
4.0
9.8
39
105
AA400
NOMESCO Finland
Electroconvulsive therapy
13.8
9.7
16
12
G72.8
ICD-10 Finland
Other specified myopathies
11.7
9.6
17
15
C07AB07
ATC
bisoprolol; oral
2.0
9.6
146
861
SPAT1254
SPAT
Administration of medicine
2.6
9.6
77
336
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
9.5
59
222
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
5.6
9.5
27
51
EBA30
NOMESCO Finland
Excision of root of tooth
4.5
9.5
33
78
D10
ICPC
Vomiting
3.2
9.5
51
175
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
102.1
9.4
10
*
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
30.8
9.4
12
*
T90
ICPC
Diabetes non-insulin dependent
2.5
9.4
77
342
KMAK
NOMESCO Finland
NA
1.9
9.4
257
1877
T40.2
ICD-10 Finland
Poisoning: Other opioids
+∞
9.4
9
*
K85
ICD-10 Finland
Acute pancreatitis
11.0
9.4
17
16
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.7
9.4
26
48
U13
ICPC
Bladder symptom/complaint other
6.3
9.4
24
40
L03.9
ICD-10 Finland
Cellulitis, unspecified
7.0
9.2
22
33
P27
ICPC
Fear of mental disorder
8.0
9.2
20
26
R50.9
ICD-10 Finland
Fever, unspecified
2.4
9.2
80
366
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.7
9.2
40
117
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
8.6
9.2
19
23
R40.2
ICD-10 Finland
Coma, unspecified
10.3
9.1
17
17
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
16.0
9.1
14
9
C03CA01
ATC
furosemide; systemic
2.5
9.1
75
335
N06AX21
ATC
duloxetine; oral
2.8
9.0
61
243
N02AA05
ATC
oxycodone; systemic
3.1
9.0
51
180
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
5.7
9.0
25
46
SPAT1395
SPAT
Health check-up of persons outside student and working life
7.7
9.0
20
27
A11
ICPC
Chest pain NOS
3.8
9.0
37
103
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
19.1
9.0
13
7
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.0
9.0
35
93
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
24.6
8.9
12
5
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
24.6
8.9
12
5
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
12.9
8.9
15
12
IGV01
NOMESCO Finland
Psychiatric network contact
11.0
8.9
16
15
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
9.8
8.8
17
18
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.9
8.8
55
209
F22.0
ICD-10 Finland
Delusional disorder
6.8
8.8
21
32
F31
ICD-10 Finland
Bipolar affective disorder
7.9
8.7
19
25
R4110
NOMESCO Finland
Physiotherapy
2.1
8.7
112
616
N05BA05
ATC
potassium clorazepate; oral
51.0
8.7
10
*
F13.09
ICD-10 Finland
Intoxication caused by sedative and hypnotic UNS
51.0
8.7
10
*
T68
ICD-10 Finland
Hypothermia
51.0
8.7
10
*
F41.8
ICD-10 Finland
Other specified anxiety disorders
4.3
8.7
31
76
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.1
8.7
26
53
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
4.8
8.6
28
62
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.8
8.6
28
62
A01
ICPC
Pain general/multiple sites
3.3
8.6
43
140
Z02.7
ICD-10 Finland
Issue of medical certificate
3.7
8.6
37
107
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.3
8.6
88
436
N05CD08
ATC
midazolam; nasal, systemic
9.3
8.6
17
19
SFA40
NOMESCO Finland
Replacement of krone of tooth
2.3
8.6
86
422
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.6
8.6
24
45
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
20.5
8.5
12
6
F20.10
ICD-10 Finland
Raise schizophrenia continuously
20.5
8.5
12
6
S21
ICPC
Skin texture symptom/complaint
2.7
8.5
57
226
EBA00
SPAT
NA
6.9
8.5
20
30
B17.1
ICD-10 Finland
Acute hepatitis C
91.7
8.4
9
*
ZYD04
NOMESCO Finland
Emergency outreach service, another specialty
91.7
8.4
9
*
R25.1
ICD-10 Finland
Tremor, unspecified
6.4
8.4
21
34
J01FF01
ATC
clindamycin; systemic
2.0
8.4
123
708
R51.80
ICD-10 Finland
Headache
2.3
8.4
82
395
M54.5
ICD-10 Finland
Low back pain
1.9
8.4
155
977
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
+∞
8.4
8
*
N05AE04
ATC
ziprasidone; systemic
9.7
8.3
16
17
F20.0
ICD-10 Finland
Paranoid schizophrenia
9.7
8.3
16
17
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.1
8.3
25
51
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
5.1
8.3
25
51
A41.9
ICD-10 Finland
Sepsis, unspecified
5.3
8.3
24
47
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.7
8.3
35
100
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
8.3
37
111
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
14.8
8.2
13
9
Z29
ICPC
Social problem NOS
5.9
8.2
22
39
K04.08
ICD-10 Finland
Other specified pulpit
3.0
8.2
48
175
Z00.0
ICD-10 Finland
General medical examination
2.3
8.2
83
408
D01
ICPC
Abdominal pain/cramps general
2.6
8.2
62
265
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.8
8.1
257
1931
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
12.0
8.1
14
12
3049X
ICD-9 Finland
Drug dependence, Unspecified drug dependence
34.0
8.1
10
*
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
34.0
8.1
10
*
F32.8
ICD-10 Finland
Other depressive episodes
6.5
8.1
20
32
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
22.5
8.0
11
5
F60.0
ICD-10 Finland
Paranoid personality disorder
22.5
8.0
11
5
L16
ICPC
Ankle symptom/complaint
2.7
8.0
55
221
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.7
8.0
26
58
N06AG02
ATC
moclobemide; oral
4.5
8.0
27
63
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
4.5
8.0
27
63
SPAT1285
SPAT
Provision of consultation response
4.3
7.9
28
68
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
5.6
7.9
22
41
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
7.9
65
288
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
8.7
7.9
16
19
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
7.9
47
174
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.7
7.9
33
94
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
7.9
89
460
WX872
NOMESCO Finland
Intensive care
4.4
7.9
27
64
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
7.9
170
1126
ZXY60
NOMESCO Finland
2-person team, nurses
9.7
7.8
15
16
WX890
NOMESCO Finland
Intesive care monitoring
15.4
7.8
12
8
ZYD01
NOMESCO Finland
Emergency clinic
15.4
7.8
12
8
IEV99
NOMESCO Finland
Other psychiatric network intervention
15.4
7.8
12
8
F30.9
ICD-10 Finland
Manic episode, unspecified
45.8
7.7
9
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
6.9
7.7
18
27
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
7.7
78
386
V03AB30
ATC
NA
18.7
7.6
11
6
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
6.4
7.6
19
31
Y34
ICD-10 Finland
Unspecified event, undetermined intent
12.1
7.6
13
11
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
25.5
7.6
10
*
ZX122
NOMESCO Finland
Intra-arterial
25.5
7.6
10
*
D11
ICPC
Diarrhoea
2.5
7.6
61
269
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.8
7.6
49
191
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
7.5
109
625
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
7.5
188
1300
Z72.0
ICD-10 Finland
Tobacco use
5.2
7.5
22
44
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
7.5
43
155
W10
ICD-10 Finland
Fall on and from stairs and steps
4.3
7.4
26
63
R33
ICD-10 Finland
Retention of urine
3.8
7.4
30
83
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
13.7
7.4
12
9
L28
ICPC
Limited function/disability (L)
2.7
7.4
53
216
K59.09
ICD-10 Finland
Constipation, unspecified
4.2
7.4
27
68
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
8.6
7.4
15
18
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
7.4
109
627
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
7.3
147
946
IFC01
NOMESCO Finland
Withdrawal and replacement therapy for opioid addiction
+∞
7.3
7
*
S82.6
ICD-10 Finland
Fracture of lateral malleolus
3.3
7.3
36
117
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.0
7.3
41
144
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.2
7.3
37
123
WX110
SPAT
NA
3.6
7.3
31
90
L05
ICPC
Flank/axilla symptom/complaint
3.7
7.2
30
85
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
7.2
103
584
Z01.7
ICD-10 Finland
Laboratory examination
2.6
7.2
52
214
N02BE01
ATC
paracetamol; systemic, rectal
1.9
7.2
355
3010
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
20.4
7.2
10
5
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.1
159
1058
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
7.1
173
1181
ZXE00
NOMESCO Finland
One hour or less
1.8
7.1
169
1145
SPAT1247
SPAT
Outpatient detoxication and monitoring
10.3
7.1
13
13
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
10.3
7.1
13
13
F20
ICD-10 Finland
Schizophrenia
10.3
7.1
13
13
U02
ICPC
Urinary frequency/urgency
2.5
7.1
55
238
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
7.0
44
166
WX882
NOMESCO Finland
High dependency care
5.3
7.0
20
39
W19
ICD-10 Finland
Unspecified fall
2.7
7.0
46
181
RS220
NOMESCO Finland
NA
6.0
7.0
18
31
OAB43
SPAT
NA
0.4
7.0
30
689
L01
ICPC
Neck symptom/complaint
2.3
7.0
62
287
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
7.7
7.0
15
20
SPAT1241
SPAT
Extensive assessment of psychosocial situation
7.7
7.0
15
20
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.5
6.9
23
53
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
6.9
94
524
N06BA04
ATC
methylphenidate; oral
4.0
6.9
26
68
D12
ICPC
Constipation
5.2
6.9
20
40
WX704
NOMESCO Finland
Intubation
3.0
6.8
39
140
SPAT1301
SPAT
No procedures
1.8
6.8
130
820
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
6.8
58
262
R03AC02
ATC
salbutamol; inhalant
1.7
6.8
224
1666
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
40.7
6.8
8
*
R44.3
ICD-10 Finland
Hallucinations, unspecified
40.7
6.8
8
*
RS120
NOMESCO Finland
NA
40.7
6.8
8
*
T43.3
ICD-10 Finland
Poisoning: Phenothiazine antipsychotics and neuroleptics
40.7
6.8
8
*
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
17.0
6.8
10
6
P77
ICPC
Suicide/suicide attempt
17.0
6.8
10
6
M54
ICD-10 Finland
Dorsalgia
2.3
6.7
63
300
30041
ICD-8 Finland
Neuroses, Depressiva
22.9
6.7
9
*
A60
ICPC
General and Unspecified, Result test/procedure
4.0
6.7
25
65
U01
ICPC
Dysuria/painful urination
2.8
6.7
42
159
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
5.6
6.7
18
33
P17
ICPC
Tobacco abuse
6.1
6.7
17
29
SPAT1260
SPAT
Consultation of another employee
2.1
6.7
75
385
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
6.6
73
372
N30.0
ICD-10 Finland
Acute cystitis
2.3
6.6
62
293
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
12.5
6.6
11
9
F40.1
ICD-10 Finland
Social phobias
4.1
6.6
24
61
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
10.2
6.6
12
12
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
10.2
6.6
12
12
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.2
6.6
12
12
Z2445
NOMESCO Finland
Psychologist
3.2
6.5
33
110
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
6.5
66
325
S00.0
ICD-10 Finland
Superficial injury of scalp
5.8
6.5
17
30
E87.6
ICD-10 Finland
Hypokalaemia
5.8
6.5
17
30
D07AA02
ATC
hydrocortisone; topical
2.1
6.5
74
382
F32
ICD-10 Finland
Depressive episode
2.8
6.5
39
146
R55
ICD-10 Finland
Syncope and collapse
2.6
6.5
46
190
Y94.0
ICD-10 Finland
Accident at home
7.6
6.5
14
19
L02
ICPC
Back symptom/complaint
2.5
6.5
49
210
Y04.2
ICD-10 Finland
Assault by bodily force by friend
70.8
6.4
7
*
RT130
NOMESCO Finland
NA
70.8
6.4
7
*
F11.2
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, dependence syndrome
70.8
6.4
7
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
70.8
6.4
7
*
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
70.8
6.4
7
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
6.4
39
147
S51.0
ICD-10 Finland
Open wound of elbow
14.6
6.4
10
7
B01AB05
ATC
enoxaparin; parenteral
1.9
6.4
99
579
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
6.4
56
257
S20.2
ICD-10 Finland
Contusion of thorax
3.7
6.4
26
73
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.1
6.4
23
58
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
6.7
6.4
15
23
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
6.7
6.4
15
23
IGY02
SPAT
NA
8.3
6.4
13
16
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
6.4
50
216
A02BC01
ATC
omeprazole; systemic
1.9
6.4
102
605
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.1
6.4
16
27
A99
ICPC
Disease/condition unspecnature/site
3.0
6.3
34
119
N05CD05
ATC
triazolam; oral, sublingual
18.3
6.3
9
5
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
18.3
6.3
9
5
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
18.3
6.3
9
5
A02BC03
ATC
lansoprazole; oral
1.9
6.3
104
620
T51.9
ICD-10 Finland
Toxic effect: Alcohol, unspecified
+∞
6.3
6
*
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
+∞
6.3
6
*
T65.0
ICD-10 Finland
Toxic effect: Cyanides
+∞
6.3
6
*
IBZ04
NOMESCO Finland
Replacement therapy evaluation for person with opioid addiction
+∞
6.3
6
*
SPAT1243
SPAT
Psychiatric/psychological examination
3.5
6.2
27
80
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
27.1
6.2
8
*
UJF32
NOMESCO Finland
Coloscopy
2.0
6.2
82
452
N80
ICPC
Head injury other
6.4
6.2
15
24
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
4.4
6.2
21
50
J20
ICD-10 Finland
Acute bronchitis
2.6
6.2
44
182
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
7.8
6.2
13
17
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
6.2
54
247
SPAT1104
SPAT
Monitoring of emergency patient
3.1
6.1
31
104
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
6.1
56
261
IHZ07
SPAT
NA
12.8
6.1
10
8
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
12.8
6.1
10
8
WVA20
SPAT
NA
12.8
6.1
10
8
ZXY49
NOMESCO Finland
Other health care provider
8.8
6.1
12
14
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.3
6.1
29
93
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
6.1
86
485
N03AF02
ATC
oxcarbazepine; oral
3.4
6.1
27
82
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.1
6.1
22
56
F32.1
ICD-10 Finland
Moderate depressive episode
2.7
6.1
39
151
X23
ICPC
Fear sexually transm dis female
2.6
6.0
45
188
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
6.0
45
189
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
128
148
11.33
106.64
7.1
2.8
—
—
—
0
0
(4198724)
74
36
24.01
99.74
3.4
1.9
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
53
15
39.47
85.34
7.3
2.1
umol/l
148.1
80.3
—
29
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
147
277
7.14
79.72
6.4
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
156
327
6.52
75.73
7.0
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
130
231
7.29
74.25
6.3
2.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
156
352
6.02
69.55
7.0
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
156
353
6.00
69.31
7.0
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
156
355
5.97
68.85
7.1
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
151
351
5.76
64.76
7.3
1.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
125
252
6.31
62.30
4.6
4.6
kpa
6.0
5.9
0.47
120
247
(3002032) Base excess in Venous blood by calculation
123
247
6.30
61.50
4.7
4.7
mmol/l
1.7
2.0
0.41
98
198
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
90
139
7.70
57.82
4.1
5.4
mmol/l
23.5
24.1
0.77
80
129
(3020191) Ethanol [Moles/volume] in Serum or Plasma
51
36
15.69
56.98
3.2
1.3
promille
1.5
1.5
0.03
33
28
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
50
37
14.93
54.39
2.1
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
117
253
5.75
53.62
11.1
8.5
mmol/l
1.3
1.3
0.05
112
245
(3023183) Ammonium ion [Moles/volume] in Plasma
60
62
10.88
52.92
2.3
4.5
umol/l
33.4
37.7
0.60
50
52
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
298
1344
4.08
51.71
5.9
3.2
u/l
34.7
32.2
0.51
275
1280
(3003396) Base excess in Arterial blood by calculation
124
294
5.30
51.07
11.6
10.3
mmol/l
0.7
1.2
0.65
105
233
(3027801) Oxygen [Partial pressure] in Arterial blood
124
295
5.28
50.85
11.7
10.2
kpa
11.5
13.1
3.17
116
283
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
124
295
5.28
50.85
11.7
10.2
kpa
5.3
5.1
0.93
117
282
(3009466) Valproate [Moles/volume] in Serum or Plasma
60
66
10.21
50.56
5.1
5.4
umol/l
373.1
369.3
0.05
48
59
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
198
686
4.15
50.00
3.2
1.8
%
1.7
1.4
5.11
169
627
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
78
136
6.63
44.32
12.8
12.4
mmol/l
24.0
24.5
0.60
70
129
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
287
1370
3.62
43.39
9.3
6.1
mmol/l
1.2
1.2
3.47
270
1261
(3023368) Bacteria identified in Blood by Culture
204
786
3.72
43.07
8.2
4.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
222
922
3.56
41.42
4.4
2.0
u/l
1016.4
290.0
0.84
215
879
(3000991) Gas panel - Venous blood
100
241
4.95
39.81
12.1
9.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
329
1775
3.57
39.65
8.3
5.9
umol/l
9.3
11.2
3.42
308
1682
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
298
1517
3.44
39.42
9.5
6.7
mmol/l
1.2
1.2
4.96
257
1288
(3024561) Albumin [Mass/volume] in Serum or Plasma
268
1322
3.25
36.55
4.8
4.9
g/l
35.7
37.0
3.12
246
1249
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
111
320
4.19
34.88
2.3
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
110
320
4.14
34.09
4.5
2.4
u/l
23.7
178.6
0.52
96
271
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
41
48
9.23
32.71
3.0
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
109
325
4.02
32.55
2.3
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
339
2007
3.21
32.13
10.1
4.8
mmol/l
6.7
6.5
0.62
319
1831
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
134
465
3.58
31.99
2.4
1.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
53
88
6.63
31.30
3.0
2.2
ug/l
969.9
319.5
0.45
48
82
(3018418) pH of Serum or Plasma
200
903
3.04
30.61
3.4
3.8
ph
7.4
7.4
0.10
42
173
(3012095) Magnesium [Moles/volume] in Serum or Plasma
136
501
3.37
29.30
3.8
3.8
mmol/l
0.8
0.8
3.72
128
475
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
403
2725
3.62
28.86
10.9
6.9
u/l
77.4
76.3
0.21
383
2565
(42870588) Differential panel, method unspecified - Blood
236
1202
2.85
28.45
8.8
5.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
118
407
3.50
28.12
4.6
6.2
mmol/l
1.0
1.0
0.11
109
381
(40758558) Short blood count panel - Blood
191
892
2.86
26.82
11.0
6.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
189
883
2.85
26.46
4.3
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
188
879
2.84
26.24
4.3
2.9
e6/l
0.4
0.3
0.36
148
653
(3013650) Neutrophils [#/volume] in Blood by Automated count
343
2181
2.88
26.02
18.6
8.9
e9/l
4.3
4.0
2.10
301
1919
(3013115) Eosinophils [#/volume] in Blood
319
1959
2.78
25.82
11.4
6.4
e9/l
0.2
0.2
0.01
278
1759
(3031040) Bacteria [#/volume] in Urine by Automated count
361
2364
2.97
25.78
6.1
3.8
e6/l
338.6
170.2
—
5
37
(3033658) Prothrombin time (PT) actual/Normal
185
865
2.82
25.73
7.2
3.5
%
91.1
94.9
1.26
179
848
(3006504) Eosinophils/100 leukocytes in Blood
299
1784
2.72
25.52
9.4
5.8
%
2.6
2.8
0.76
282
1681
(3001604) Monocytes [#/volume] in Blood
310
1885
2.74
25.44
9.3
5.9
e9/l
0.6
0.6
3.20
270
1664
(3042936) Bacteria identified in Isolate by Culture
123
461
3.22
25.42
2.6
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
203
1003
2.74
25.29
6.1
3.3
mmol/l
6.7
8.7
7.04
179
858
(3019069) Monocytes/100 leukocytes in Blood
299
1793
2.70
25.11
9.7
6.2
%
8.2
8.3
0.47
286
1705
(3006315) Basophils [#/volume] in Blood
310
1895
2.71
25.00
9.3
5.9
e9/l
0.0
0.0
0.44
270
1673
(3002582) Erythrocytes [#/volume] in Urine
199
985
2.71
24.56
4.4
3.0
e6/l
63.0
43.3
0.25
157
752
(3002030) Lymphocytes/100 leukocytes in Blood
306
1872
2.67
24.42
9.5
5.8
%
29.5
29.5
0.03
292
1780
(3019198) Lymphocytes [#/volume] in Blood
316
1964
2.70
24.41
9.5
6.0
e9/l
2.2
2.0
1.31
277
1770
(3018010) Neutrophils/100 leukocytes in Blood
302
1846
2.64
23.97
9.2
5.7
%
56.0
56.1
0.06
288
1755
(3018095) Leukocytes [#/volume] in Urine
224
1188
2.62
23.88
5.1
3.4
e6/l
62.4
117.7
0.62
166
806
(3022096) Basophils/100 leukocytes in Blood
288
1723
2.61
23.87
9.7
6.0
%
0.6
0.7
1.57
273
1626
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
211
1089
2.64
23.77
4.5
2.6
u/l
52.1
55.5
0.81
195
1022
(3015377) Calcium [Moles/volume] in Serum or Plasma
205
1048
2.64
23.49
3.3
3.0
mmol/l
2.3
2.4
0.63
184
937
(3019309) Folate [Moles/volume] in Red Blood Cells
117
446
3.13
23.33
1.9
1.6
nmol/l
1112.0
1209.7
0.50
88
349
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
218
1152
2.60
23.28
4.3
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
147
638
2.86
23.20
3.3
2.5
mosm/kgh2o
464.3
568.6
4.73
126
538
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
58
138
4.63
23.00
2.2
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
111
414
3.17
22.94
2.7
2.8
umol/l
6.2
8.3
0.74
95
347
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
59
144
4.52
22.66
12.9
14.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
93
314
3.42
22.60
6.4
2.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
67
185
4.03
21.87
1.7
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
131
551
2.88
21.77
5.2
3.1
ng/l
142.2
360.8
1.22
76
347
(3000850) Epithelial cells [#/volume] in Urine
147
676
2.67
20.42
3.5
2.6
e6/l
7.7
5.6
1.08
131
587
(1616796) Gas panel - Central venous blood
35
60
6.20
19.90
4.8
3.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
275
1702
2.39
19.86
14.4
8.1
e9/l
0.0
0.0
0.37
227
1398
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
64
186
3.80
19.38
1.7
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
143
675
2.58
18.62
2.0
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
106
433
2.84
18.33
2.0
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
71
5.39
17.68
1.3
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
104
431
2.79
17.44
2.2
2.2
s
30.3
29.8
0.35
97
422
(3016650) Hepatitis A virus Ab [Presence] in Serum
38
80
5.06
17.36
1.3
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
206
1176
2.29
17.31
2.3
1.7
pmol/l
93.6
95.8
0.29
117
609
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
23
9
26.71
17.05
1.1
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
111
481
2.69
17.04
3.4
2.7
e6/l
4.6
2.4
0.87
61
261
(3032080) INR in Blood by Coagulation assay
203
1159
2.28
16.99
9.8
6.3
inr
1.1
1.1
0.81
70
401
(3019150) Specific gravity of Urine by Refractometry
161
837
2.37
16.74
6.0
3.2
kg/l
1.0
1.0
2.49
32
111
(3021960) Folate [Moles/volume] in Serum or Plasma
138
672
2.46
16.58
1.5
1.4
nmol/l
19.0
20.4
0.60
125
581
(3019060) Gas panel - Arterial blood
56
168
3.63
16.13
7.9
7.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
392
2976
2.55
16.01
5.3
3.8
pmol/l
14.5
14.5
0.00
366
2751
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
111
498
2.59
15.80
3.4
2.6
e6/l
0.9
1.1
0.19
61
279
(3012501) Base excess in Blood by calculation
31
60
5.45
15.53
6.9
2.9
mmol/l
2.5
2.6
0.07
20
40
(3026008) Bacteria identified in Urine by Culture
165
899
2.26
15.12
4.0
2.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
385
2933
2.43
15.02
7.0
2.9
u/l
53.6
41.4
2.57
365
2809
(3004789) Transferrin [Mass/volume] in Serum or Plasma
99
434
2.60
14.70
1.8
2.1
g/l
2.4
2.4
0.03
88
401
(3022948) Iron [Moles/volume] in Serum or Plasma
105
474
2.54
14.67
1.8
2.2
umol/l
12.5
14.6
1.65
94
439
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
194
1149
2.14
14.26
5.2
3.0
ng/l
237.8
37.6
0.46
114
625
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
66
4.95
13.96
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
66
4.95
13.96
1.6
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
26
48
5.66
13.67
2.7
2.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
29
60
5.07
13.49
2.6
5.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
18
7
26.60
13.45
4.7
2.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
106
500
2.43
13.39
2.8
2.5
mmol/l
2.4
2.4
0.35
92
432
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
117
577
2.35
13.37
1.9
1.6
pmol/l
497.4
42442285.9
1.07
105
516
(46235355) HIV 1 and 2 tests - Meaningful Use set
207
1291
2.04
12.96
2.9
2.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
13
11.05
12.91
2.4
2.2
umol/l
13.4
13.8
0.06
14
13
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
40
5.98
12.85
1.1
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
89
402
2.48
12.29
1.8
2.2
%
19.1
25.0
3.19
74
351
(3044889) 12 lead EKG panel
327
2428
2.03
12.17
5.1
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
144
801
2.13
12.13
2.5
2.0
mg/l
2.7
2.9
0.53
124
699
(40767503) Oxygen content in Capillary blood by calculation
25
50
5.21
12.07
4.2
2.6
%
17.5
17.0
0.17
12
22
(3006184) Hemoglobin [Mass/volume] in Capillary blood
28
62
4.73
12.04
2.1
2.6
g/l
134.7
132.5
0.16
21
44
(3036481) Cortisol [Moles/volume] in Serum or Plasma
80
348
2.55
11.94
1.7
1.9
nmol/l
377.0
370.3
0.10
70
326
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
428
3550
2.56
11.71
6.6
4.4
mu/l
1.8
2.1
0.55
413
3327
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
431
2.39
11.70
2.0
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
352
2707
2.05
11.57
3.5
3.6
mm/h
11.5
8.9
3.09
320
2524
(3037467) Urinalysis macro (dipstick) panel - Urine
341
2594
2.02
11.54
5.3
3.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
23
45
5.31
11.37
2.3
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
39
117
3.53
11.20
5.8
3.3
%
52.4
50.9
0.11
39
117
(3019550) Sodium [Moles/volume] in Serum or Plasma
449
3838
2.90
11.05
31.7
11.4
mmol/l
139.0
139.6
5.27
442
3728
(3022217) INR in Platelet poor plasma by Coagulation assay
71
303
2.57
10.99
20.7
14.5
inr
1.2
1.2
0.05
12
45
(3009343) pH of Capillary blood
53
195
2.92
10.90
3.4
3.0
ph
7.4
7.4
—
9
21
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
138
788
2.04
10.66
2.1
1.8
mg/l
0.9
1.0
0.25
103
583
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
166
1014
1.96
10.58
2.0
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
448
3853
2.78
10.35
31.3
11.4
mmol/l
3.9
4.0
0.43
441
3730
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
103
3.58
10.34
1.3
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
51
191
2.86
10.15
2.7
3.0
mmol/l
2.2
1.4
0.57
33
131
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
65
287
2.46
9.33
2.1
2.7
g/l
0.2
0.2
0.90
59
266
(21494755) Public health laboratory ask at order entry panel
19
653
0.26
8.61
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
144
893
1.87
8.47
2.6
2.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
253
1856
1.75
8.41
4.7
3.1
estimate
0.0
0.0
0.00
60
379
(3027945) Reticulocytes/100 erythrocytes in Blood
61
276
2.38
8.29
1.7
3.2
%
1.7
1.7
0.06
54
248
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
153
979
1.82
8.09
2.8
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
33
110
3.14
8.05
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
110
635
1.94
8.00
2.8
3.1
ng/l
1448.7
845.5
0.43
90
505
(3044290) Cell count panel - Cerebral spinal fluid
26
75
3.60
7.93
1.6
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
421
3628
2.10
7.90
22.9
9.3
ml/min/173m2
98.6
92.4
6.54
360
2907
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
53
232
2.44
7.74
3.8
3.7
mmol/l
1.2
1.2
0.83
48
206
(3052851) Hemolysis interference index of Serum or Plasma
29
92
3.29
7.66
4.1
3.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
205
1446
1.72
7.63
2.5
2.3
nmol/l
72.7
72.7
0.01
192
1331
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
450
3996
2.45
7.59
27.7
10.8
mg/l
23.0
20.8
0.89
393
3076
(3044640) Blood type and Crossmatch panel - Blood
163
1086
1.75
7.40
2.9
2.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
48
205
2.49
7.39
2.2
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
247
1859
1.66
7.02
6.2
4.2
estimate
0.0
0.0
0.50
61
390
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
46
198
2.46
6.97
3.5
2.2
ug/l
13.9
9.1
0.52
39
183
(3023511) Choriogonadotropin [Units/volume] in Urine
40
161
2.62
6.95
2.3
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
249
1884
1.65
6.89
4.7
3.1
estimate
0.0
0.0
0.00
58
370
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
27
89
3.15
6.72
1.7
1.4
e6/l
18.5
146.4
1.08
20
72
(3011397) Hemoglobin [Presence] in Urine by Test strip
124
784
1.78
6.66
3.5
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
81
450
1.96
6.52
1.2
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
29
4.94
6.49
1.9
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
226
1689
1.62
6.43
4.4
4.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
149
1004
1.69
6.34
4.9
3.3
estimate
0.0
0.0
0.80
59
384
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
26
89
3.03
6.09
1.7
1.3
e6/l
1.3
9.0
1.22
18
69
(3020891) Body temperature
29
106
2.84
6.06
10.4
4.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
111
1652
0.58
6.06
3.1
2.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
400
3487
1.78
5.88
36.9
13.1
%
13.8
13.4
5.13
394
3431
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
91
2.96
5.87
2.0
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
532
0.33
5.76
1.6
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
77
441
1.88
5.64
2.2
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
45
213
2.22
5.52
5.2
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
25
4.89
5.52
3.7
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
233
1803
1.55
5.43
3.0
2.7
ug/l
98.9
104.1
0.15
219
1706
(3007463) Buprenorphine [Presence] in Urine
8
5
16.24
5.42
4.5
5.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
224
2.16
5.27
1.4
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
121
806
1.66
5.26
2.9
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
411
3645
1.77
5.26
5.2
3.5
mmol/l
6.1
5.8
2.12
386
3387
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
0
+∞
5.21
1.4
0.0
mmol/l
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
70
3.09
5.16
3.6
4.0
e9/l
4.5
4.4
0.07
21
70
(3000494) Fungus identified in Specimen by Culture
71
411
1.85
5.02
1.3
1.5
—
—
—
0
0
(4010399)
48
243
2.08
4.99
1.4
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
459
4234
2.22
4.99
17.2
8.6
u/l
32.2
28.8
1.98
449
4119
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
381
3334
1.63
4.87
5.7
4.6
mmol/mol
38.0
38.5
0.37
356
3160
(40761536) Microorganisms panel - Urine sediment
62
348
1.89
4.82
5.4
3.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
29
4.22
4.65
1.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
75
2.88
4.61
3.7
4.0
%
58.8
56.6
0.37
21
75
(3051651) Icteric interference index of Serum or Plasma
10
21
4.84
4.55
2.7
4.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
25
99
2.61
4.54
1.5
2.0
g/l
1.7
1.3
1.29
20
89
(3035637) Corticotropin [Mass/volume] in Plasma
14
39
3.67
4.51
1.4
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
38
185
2.14
4.38
1.6
2.9
e9/l
66.2
74.7
0.70
20
134
(3001019) Free T4 and TSH panel - Serum or Plasma
9
288
0.30
4.38
1.2
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
26
4.30
4.37
1.5
8.0
%
12.6
12.3
0.09
11
26
(3023410) Appearance of Cerebral spinal fluid
14
40
3.57
4.36
2.1
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
15
45
3.41
4.36
1.5
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
18
61
3.02
4.32
9.9
13.1
mmol/l
11.7
11.4
0.17
18
54
(3018572) Chloride [Moles/volume] in Blood
18
62
2.98
4.21
9.9
12.9
mmol/l
104.3
105.3
0.40
18
55
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
62
2.98
4.21
3.3
2.8
u/ml
0.3
0.3
0.13
12
30
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
13
7.03
4.18
2.2
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
84
547
1.65
3.93
2.5
2.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
83
2.60
3.85
1.4
1.4
ug/g
265.5
275.2
0.06
11
46
(3051611) Lipemic interference index of Serum or Plasma
11
29
3.86
3.82
2.6
4.2
—
—
—
0
0
(3004451) EKG impression Narrative
8
12
6.75
3.68
1.6
1.4
—
—
—
0
0
(3013512) EKG study
116
828
1.52
3.66
4.5
3.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
35
3.49
3.64
1.9
1.6
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
7
9
7.87
3.57
3.4
5.0
mmol/l
24.0
25.1
—
7
9
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
26
3.91
3.53
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
26
3.91
3.53
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
366
0.39
3.39
1.5
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
52
310
1.76
3.36
2.2
2.5
g/l
10.7
10.2
0.41
43
275
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
84
2.44
3.27
1.1
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
63
400
1.66
3.25
1.8
2.3
nmol/l
13.6
14.0
0.14
54
373
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
37
205
1.87
3.04
1.6
3.9
ng/l
85.7
73.4
0.24
30
190
(3017181) Myelocytes/100 leukocytes in Blood
49
296
1.73
3.04
5.9
4.7
%
0.5
0.8
0.48
14
84
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
49
298
1.72
2.97
2.8
2.5
u/l
3833.6
2927.8
0.13
13
134
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
17
4.76
2.93
1.0
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
107
789
1.45
2.84
3.0
3.4
mg/l
697.5
323.5
0.24
64
520
(3021788) Differential panel - Synovial fluid
12
42
2.90
2.77
2.0
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
289
0.40
2.66
1.2
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
43
2.84
2.66
1.3
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
23
113
2.09
2.66
1.9
2.8
g/l
3.7
3.6
0.15
23
107
(3023323) Follitropin [Units/volume] in Serum or Plasma
39
230
1.76
2.65
1.7
1.4
iu/l
21.0
21.0
0.01
29
194
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
123
943
1.41
2.63
1.6
1.7
mmol/l
1.7
1.4
2.13
107
817
(3025941) Bacteria identified in Stool by Culture
39
232
1.74
2.58
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
20
4.05
2.57
1.8
2.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
7
7.20
2.55
9.4
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
205
0.38
2.48
1.6
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
37
220
1.74
2.46
1.2
1.4
miu/ml
264.8
254.8
0.04
12
119
(3002179) Metamyelocytes/100 leukocytes in Blood
44
276
1.65
2.41
4.6
4.5
%
0.4
0.4
—
10
58
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
181
1495
1.33
2.40
5.0
3.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
53
350
1.58
2.37
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
44
280
1.63
2.29
6.2
4.8
%
0.1
0.1
0.20
12
76
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
60
2.37
2.23
3.2
3.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
42
267
1.63
2.20
6.4
4.9
%
0.0
0.0
—
10
63
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
30
3.04
2.15
3.2
4.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
145
1.84
2.15
3.7
3.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
25
425
0.57
2.08
1.4
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
10
5.04
2.07
1.2
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
26
147
1.81
2.06
2.1
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
106
824
1.36
2.06
4.2
4.3
mg/mmol
7.1
10.8
0.62
61
532
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
20
3.53
2.06
1.1
2.9
ug/l
14.6
15.5
—
7
20
(40761511) CBC panel - Blood by Automated count
448
4269
1.54
2.06
24.5
9.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
15
4.04
2.04
1.2
1.5
nmol/l
194.2
159.5
—
6
15
(3005570) Glucose [Moles/volume] in Urine
9
32
2.85
2.01
5.7
1.9
—
—
—
0
0
(4306422)
15
70
2.18
2.00
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
37
234
1.63
2.00
2.7
2.3
ml/min/173m2
68.8
73.3
0.26
17
99
(40760892) CBC W Ordered Manual Differential panel - Blood
121
966
1.33
1.98
5.9
4.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
84
2.06
1.98
1.7
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
141
1153
1.31
1.95
4.9
2.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
71
2.15
1.94
3.4
2.4
ug/min
19.1
118.0
—
7
45
(3044941) Cell count panel - Synovial fluid
10
39
2.60
1.93
1.8
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
127
1028
1.32
1.88
1.3
1.3
u/ml
7.3
1.5
0.56
15
291
(3048689) Calprotectin [Mass/mass] in Stool
77
579
1.39
1.84
2.4
2.7
ug/g
116.3
116.1
0.00
59
466
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
12
4.20
1.82
1.0
2.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
12
4.20
1.82
1.0
2.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
37
240
1.59
1.82
3.9
3.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
23
3.07
1.80
1.1
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
27
162
1.71
1.79
2.7
2.7
e6/l
0.4
0.1
0.45
27
155
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
163
0.42
1.69
1.4
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
119
1.80
1.69
6.0
4.9
g/l
0.1
0.2
—
9
64
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
50
356
1.45
1.62
12.1
6.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
32
2.52
1.60
1.1
2.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
137
1.71
1.58
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
14
71
2.00
1.55
1.1
1.2
%
126.9
117.7
0.52
14
65
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
27
2.61
1.52
1.4
1.8
pg
29.4
33.2
—
7
27
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
21
2.88
1.51
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
111
909
1.29
1.50
1.3
1.4
g/l
2.6
2.2
0.76
54
593
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
124
1.72
1.49
1.3
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
708
0.72
1.48
1.5
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
10
45
2.25
1.47
5.3
2.5
mmol/l
7.8
7.5
—
10
45
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
125
1.71
1.46
1.3
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
16
3.15
1.44
1.6
2.6
umol/l
17.2
27.7
—
5
16
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
82
649
1.32
1.43
1.3
1.3
iu/ml
25.9
25.4
0.02
34
214
(3000330) Specific gravity of Urine by Test strip
22
134
1.67
1.41
4.3
2.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
40
2.27
1.40
1.2
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
222
0.53
1.38
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
222
0.53
1.38
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
221
0.53
1.37
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
221
0.53
1.37
1.5
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
30
200
1.53
1.36
1.6
1.8
nmol/l
35.0
36.0
0.10
30
193
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
75
1.89
1.35
1.3
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
21
128
1.67
1.35
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
96
786
1.27
1.30
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
412
3933
1.29
1.29
33.6
11.3
%
39.4
41.1
3.79
297
3239
(4027681)
8
35
2.31
1.27
1.4
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
189
0.52
1.25
1.5
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
25
2.42
1.24
1.0
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
69
545
1.31
1.23
1.4
1.4
titre
413.3
459.4
0.13
12
109
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
100
832
1.25
1.19
1.7
2.3
umol/l
327.1
4984.5
2.45
84
741
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
141
1.59
1.19
1.5
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
26
2.32
1.19
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
39
2.07
1.15
1.3
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
5
20
2.51
1.15
1.0
6.3
—
7.4
—
0
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
31
2.28
1.10
3.9
2.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
31
2.28
1.10
3.9
2.3
mmol/l
108.9
105.4
—
7
31
(3041354) Potassium [Moles/volume] in Venous blood
7
31
2.28
1.10
3.9
2.3
mmol/l
3.8
4.0
—
7
31
(3041806) Other cells [#/volume] in Blood by Manual count
7
31
2.28
1.10
1.6
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
194
1.47
1.09
1.8
1.5
u/l
9.0
8.5
0.08
18
160
(3000492) Spirometry study
56
439
1.31
1.07
1.6
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
121
1.59
1.07
2.5
2.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
240
0.61
1.06
1.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
75
613
1.26
1.05
1.2
1.3
u/ml
12.9
7.6
0.25
27
259
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
22
2.29
1.03
1.0
1.1
iu/ml
313.7
186.7
—
5
22
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
34
2.07
1.03
1.4
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
47
1.93
1.02
1.2
1.1
—
—
—
0
0
(4268621)
10
53
1.91
1.02
2.8
2.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
1.4
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
76
1.73
0.99
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
36
1.96
0.97
1.1
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
77
1.71
0.96
1.6
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
37
1.90
0.94
1.0
1.2
—
300.0
—
0
6
(3008898) HLA-B27 [Presence]
14
219
0.63
0.92
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
110
1.56
0.91
1.5
2.1
iu/l
5.1
6.4
—
5
46
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
79
1.66
0.89
1.3
1.3
u/ml
11.7
4.7
—
6
29
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
43
1.87
0.87
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
43
1.87
0.87
1.4
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
145
1.47
0.86
2.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
44
1.83
0.86
1.3
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
143
1273
1.17
0.86
1.5
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
177
0.61
0.83
1.5
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
65
1.71
0.83
1.3
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
176
0.62
0.81
1.5
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
58
1.74
0.80
1.5
1.5
—
—
—
0
0
(3036603) Volume of Urine
0
25
0.00
0.79
0.0
1.9
—
2077.8
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
349
3335
1.16
0.77
3.9
3.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
6
34
1.77
0.76
3.3
2.9
—
44.6
—
0
10
(3014051) Protein [Presence] in Urine by Test strip
11
67
1.66
0.75
3.0
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
24
2.09
0.74
1.2
2.1
—
17.5
—
0
9
(4146454)
5
25
2.01
0.73
1.2
3.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
39
1.81
0.72
1.1
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
117
1.47
0.72
2.5
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
319
1.28
0.72
1.2
1.3
iu/ml
226.5
150.4
—
10
134
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
124
1108
1.16
0.71
1.7
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
58
1.56
0.70
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
135
1.42
0.70
1.7
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
49
403
1.24
0.69
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
86
1.53
0.66
1.2
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
45
545
0.81
0.66
2.0
2.4
ug/l
0.6
0.6
0.44
27
286
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
28
1.79
0.66
1.2
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
242
1.30
0.66
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
44
1.60
0.65
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
44
1.60
0.65
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
44
1.60
0.65
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.0
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
87
1.51
0.64
1.2
1.6
—
—
—
0
0
(1002224) Polysomnography panel
15
211
0.70
0.63
1.1
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
49
1.64
0.62
2.1
3.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
49
1.64
0.62
1.3
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
63
1.60
0.62
1.2
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.4
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
8
50
1.61
0.61
1.5
2.3
%
5.4
1.6
—
8
41
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
51
1.58
0.60
1.3
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
466
4587
1.29
0.60
41.6
15.6
e9/l
262.8
255.4
1.64
460
4493
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.1
—
0.3
—
0
17
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
64
1.57
0.59
2.5
2.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
23
0.00
0.58
0.0
5.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
23
0.00
0.58
0.0
2.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
89
0.56
0.56
1.0
1.1
—
5.7
—
0
19
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
182
0.71
0.55
1.5
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
38
1.59
0.54
1.0
1.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
466
4593
1.27
0.54
41.5
15.5
pg
30.2
30.1
0.33
461
4544
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
62
1.46
0.53
2.1
3.8
u/ml
452.5
3.3
—
9
56
(3024731) MCV [Entitic volume]
466
4594
1.26
0.52
41.5
15.5
fl
90.3
89.9
0.96
461
4546
(3026361) Erythrocytes [#/volume] in Blood
466
4594
1.26
0.52
41.6
15.6
e12/l
4.5
4.6
7.59
458
4490
(3049717) Cytology report of Urine Cyto stain
12
83
1.46
0.52
1.8
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
64
1.41
0.51
1.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
65
1.39
0.51
2.1
3.4
—
1.4
—
0
10
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
67
1.50
0.50
4.4
3.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
726
0.86
0.49
3.3
3.2
%
20.7
21.9
0.19
21
252
(3010813) Leukocytes [#/volume] in Blood
466
4598
1.25
0.48
42.1
15.6
e9/l
7.4
6.7
10.39
458
4490
(3000963) Hemoglobin [Mass/volume] in Blood
466
4598
1.25
0.48
42.0
15.7
g/l
134.2
138.7
8.89
460
4546
(40768793) Breast Pathology biopsy report
5
81
0.61
0.46
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
240
0.78
0.43
1.8
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
267
1.21
0.43
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.0
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
16
0.00
0.41
0.0
1.0
—
105.1
—
0
11
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
16
0.00
0.41
0.0
1.0
—
139.5
—
0
16
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
16
0.00
0.41
0.0
1.0
—
95.7
—
0
11
(3043410) Blood group antigens tested for on Red Blood Cells
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
81
733
1.13
0.41
1.5
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
79
1.40
0.41
1.5
2.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
33
279
1.20
0.40
3.4
3.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
105
0.66
0.39
1.1
2.2
mg/l
10.5
10.8
—
7
98
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
(4281824)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
206
1.23
0.38
1.1
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
66
1.37
0.38
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
43
491
0.86
0.37
1.7
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
143
1.27
0.37
2.5
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
135
0.74
0.36
1.9
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
18
144
1.26
0.35
1.4
2.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
1.3
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
109
1.29
0.34
1.1
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
155
0.77
0.33
1.4
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
83
1.33
0.32
1.1
2.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
53
1.33
0.31
1.3
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
377
3700
1.08
0.28
4.2
3.3
mmol/l
1.5
1.3
4.25
354
3481
(3002256) Pathology report gross observation
37
412
0.89
0.24
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
82
0.73
0.24
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.0
1.8
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.6
2.9
nmol/l
2.5
3.1
—
5
38
(4094501)
7
92
0.76
0.22
1.1
1.1
—
—
—
0
0
(44790048)
5
40
1.25
0.22
1.0
1.6
—
—
—
0
0
(44790047)
5
40
1.25
0.22
1.0
1.6
—
—
—
0
0
(44790049)
5
40
1.25
0.22
1.0
1.6
—
—
—
0
0
(44806118)
5
40
1.25
0.22
1.0
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
116
1.21
0.22
1.0
1.3
—
—
—
0
0
(4062490)
5
41
1.22
0.22
1.4
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
10
0.00
0.21
0.0
2.0
—
373.4
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
12
0.00
0.21
0.0
1.8
—
3.4
—
0
12
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
43
1.16
0.21
1.4
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
32.3
—
0
14
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
133
0.82
0.19
3.5
2.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
393
3881
1.06
0.19
4.9
3.9
mmol/l
2.7
2.9
4.92
368
3643
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
61
1.15
0.17
1.0
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
76
0.79
0.15
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
81
1.11
0.15
1.7
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
84
1.19
0.14
1.2
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
127
0.86
0.12
3.5
1.5
g/l
1.1
1.2
0.41
11
117
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
12
106
1.14
0.10
1.4
1.6
nmol/l
0.2
0.4
—
7
86
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
46
1.09
0.09
1.4
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
11
124
0.88
0.09
3.5
1.5
g/l
0.2
0.2
0.09
11
116
(40768804) Tissue Pathology biopsy report
145
1420
1.03
0.09
2.0
1.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(4034850)
14
127
1.11
0.08
29.1
10.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
75
0.80
0.07
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
132
0.91
0.06
1.2
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
101
0.89
0.06
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
95
930
1.03
0.06
3.4
3.4
ug/l
13.8
1.6
0.50
80
854
(4035726)
24
251
0.95
0.04
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
281
1.03
0.02
1.3
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
104
1.06
0.01
1.6
1.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
144
1.04
0.00
1.1
1.1
—
2.3
—
0
23
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
134
0.97
0.00
1.2
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
10
103
0.97
0.00
1.7
1.2
—
2.3
—
0
6
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
383
3832
1.00
0.00
4.5
3.6
mmol/l
1.3
1.4
3.89
361
3616
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
385
3849
1.00
0.00
4.5
3.7
mmol/l
4.5
4.7
4.56
363
3642
(4038314)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
9
0.00
0.00
0.0
1.7
—
143.2
—
0
9
(3036048) Francisella tularensis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
56
0.89
0.00
1.0
5.7
u/ml
—
3898.6
—
0
7
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
52.0
—
0
6
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
2.0
—
0
5
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.8
—
0.4
—
0
6
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
1.9
—
0
8
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
78
0.90
0.00
1.1
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.0
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
7
0.00
0.00
0.0
2.7
—
7969.7
—
0
7
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
28.4
—
0
7
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
6.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TOXIC_EFFECT_OTHER_UNSPE_SUBST – Toxic effect of other and unspecified substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).